Purpose of the Study

The purpose of this study is to evaluate the safety and effectiveness of an investigational medication for treating COVID-19 in high-risk individuals who are unable to take standard antiviral treatments like Paxlovid.

Study Requirements

To qualify you must:

• You are 18 years of age or older
• You have symptoms of COVID-19 that started within the past 4 days
• You are at increased risk of severe COVID-19 illness due to any of the following:

• Being 75 years of age or older
• Immunocompromised
• You have a Neurocognitive or Physical Disability
• You have 3 or more of the following risk factors: being 65 to 74 years of age, lung, cardiovascular, rheumatologic, gastrointestinal, or kidney diseases, HIV infection, cerebrovascular events, mental health conditions

Potential Benefits of Participation

Maginfying

Access to new treatments that are
not yet available to the general public.

Hand Heart

Personalized medical attention from
leading healthcare professionals.

Helios

Compensation provided up
to $1,690 for study-related time
and travel

Study Locations

This study is currently enrolling at the following sites:

Helios Clinical - Jackson, TN (26 Stonecreek Circle, 38305)
Helios Clinical - Paradise Valley (10565 N. Tatum Blvd, 85253)

About Helios Clinical

Helios Clinical is dedicated to advancing medical research through innovative clinical trials.
Our mission is to discover new ways to improve patient health and outcomes.
We collaborate with leading healthcare professionals and scientists
to ensure the highest standards of research and care for our participants.